nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0502	0.0684	CbGbCtD
Flecainide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0472	0.0643	CbGbCtD
Flecainide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0472	0.0643	CbGbCtD
Flecainide—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0459	0.0625	CbGbCtD
Flecainide—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0432	0.0588	CbGbCtD
Flecainide—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0432	0.0588	CbGbCtD
Flecainide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0427	0.0581	CbGbCtD
Flecainide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0427	0.0581	CbGbCtD
Flecainide—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.039	0.0532	CbGbCtD
Flecainide—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.039	0.0532	CbGbCtD
Flecainide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0369	0.0502	CbGbCtD
Flecainide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0358	0.0487	CbGbCtD
Flecainide—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0337	0.0459	CbGbCtD
Flecainide—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0327	0.0446	CbGbCtD
Flecainide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0324	0.0441	CbGbCtD
Flecainide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0324	0.0441	CbGbCtD
Flecainide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.031	0.0422	CbGbCtD
Flecainide—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0296	0.0403	CbGbCtD
Flecainide—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0296	0.0403	CbGbCtD
Flecainide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00021	0.000792	CcSEcCtD
Flecainide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00021	0.000792	CcSEcCtD
Flecainide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.000791	CcSEcCtD
Flecainide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.00079	CcSEcCtD
Flecainide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.00079	CcSEcCtD
Flecainide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.00079	CcSEcCtD
Flecainide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.00079	CcSEcCtD
Flecainide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000209	0.000787	CcSEcCtD
Flecainide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000787	CcSEcCtD
Flecainide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000785	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000784	CcSEcCtD
Flecainide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000208	0.000782	CcSEcCtD
Flecainide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000207	0.000781	CcSEcCtD
Flecainide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000207	0.000781	CcSEcCtD
Flecainide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.00078	CcSEcCtD
Flecainide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.00078	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.000779	CcSEcCtD
Flecainide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000779	CcSEcCtD
Flecainide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000206	0.000774	CcSEcCtD
Flecainide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000206	0.000774	CcSEcCtD
Flecainide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000774	CcSEcCtD
Flecainide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.000773	CcSEcCtD
Flecainide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000773	CcSEcCtD
Flecainide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000772	CcSEcCtD
Flecainide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000771	CcSEcCtD
Flecainide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.00077	CcSEcCtD
Flecainide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.00077	CcSEcCtD
Flecainide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000204	0.000769	CcSEcCtD
Flecainide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.000768	CcSEcCtD
Flecainide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000768	CcSEcCtD
Flecainide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000203	0.000766	CcSEcCtD
Flecainide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000203	0.000766	CcSEcCtD
Flecainide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000765	CcSEcCtD
Flecainide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.000765	CcSEcCtD
Flecainide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000764	CcSEcCtD
Flecainide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000763	CcSEcCtD
Flecainide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.000763	CcSEcCtD
Flecainide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.000762	CcSEcCtD
Flecainide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.00076	CcSEcCtD
Flecainide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.00076	CcSEcCtD
Flecainide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.00076	CcSEcCtD
Flecainide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.00076	CcSEcCtD
Flecainide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000757	CcSEcCtD
Flecainide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000757	CcSEcCtD
Flecainide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.0002	0.000755	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000755	CcSEcCtD
Flecainide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000753	CcSEcCtD
Flecainide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000751	CcSEcCtD
Flecainide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000748	CcSEcCtD
Flecainide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000198	0.000746	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.000746	CcSEcCtD
Flecainide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000745	CcSEcCtD
Flecainide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.000744	CcSEcCtD
Flecainide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000743	CcSEcCtD
Flecainide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000743	CcSEcCtD
Flecainide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000197	0.000743	CcSEcCtD
Flecainide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000742	CcSEcCtD
Flecainide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000741	CcSEcCtD
Flecainide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000197	0.000741	CcSEcCtD
Flecainide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000197	0.00074	CcSEcCtD
Flecainide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.00074	CcSEcCtD
Flecainide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000739	CcSEcCtD
Flecainide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.000739	CcSEcCtD
Flecainide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000738	CcSEcCtD
Flecainide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000196	0.000738	CcSEcCtD
Flecainide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.000738	CcSEcCtD
Flecainide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000735	CcSEcCtD
Flecainide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000735	CcSEcCtD
Flecainide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.000735	CcSEcCtD
Flecainide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000732	CcSEcCtD
Flecainide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.000732	CcSEcCtD
Flecainide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.000732	CcSEcCtD
Flecainide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000194	0.000731	CcSEcCtD
Flecainide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000194	0.000731	CcSEcCtD
Flecainide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.00073	CcSEcCtD
Flecainide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000194	0.00073	CcSEcCtD
Flecainide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000728	CcSEcCtD
Flecainide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000728	CcSEcCtD
Flecainide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000193	0.000727	CcSEcCtD
Flecainide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000725	CcSEcCtD
Flecainide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000725	CcSEcCtD
Flecainide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000725	CcSEcCtD
Flecainide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000722	CcSEcCtD
Flecainide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000721	CcSEcCtD
Flecainide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.00072	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.00072	CcSEcCtD
Flecainide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000191	0.000719	CcSEcCtD
Flecainide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000717	CcSEcCtD
Flecainide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000716	CcSEcCtD
Flecainide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00019	0.000716	CcSEcCtD
Flecainide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00019	0.000716	CcSEcCtD
Flecainide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000714	CcSEcCtD
Flecainide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00019	0.000714	CcSEcCtD
Flecainide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000713	CcSEcCtD
Flecainide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000189	0.000712	CcSEcCtD
Flecainide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.000711	CcSEcCtD
Flecainide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000709	CcSEcCtD
Flecainide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000188	0.000708	CcSEcCtD
Flecainide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000188	0.000708	CcSEcCtD
Flecainide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000708	CcSEcCtD
Flecainide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000707	CcSEcCtD
Flecainide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000707	CcSEcCtD
Flecainide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000187	0.000706	CcSEcCtD
Flecainide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.000706	CcSEcCtD
Flecainide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000187	0.000706	CcSEcCtD
Flecainide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.000705	CcSEcCtD
Flecainide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000704	CcSEcCtD
Flecainide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000187	0.000704	CcSEcCtD
Flecainide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000186	0.000702	CcSEcCtD
Flecainide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000186	0.000702	CcSEcCtD
Flecainide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000701	CcSEcCtD
Flecainide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.0007	CcSEcCtD
Flecainide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.0007	CcSEcCtD
Flecainide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.000699	CcSEcCtD
Flecainide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000185	0.000698	CcSEcCtD
Flecainide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000185	0.000696	CcSEcCtD
Flecainide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000185	0.000695	CcSEcCtD
Flecainide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000695	CcSEcCtD
Flecainide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000694	CcSEcCtD
Flecainide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000184	0.000691	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.00069	CcSEcCtD
Flecainide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000183	0.000689	CcSEcCtD
Flecainide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.000689	CcSEcCtD
Flecainide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000685	CcSEcCtD
Flecainide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000684	CcSEcCtD
Flecainide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000682	CcSEcCtD
Flecainide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000681	CcSEcCtD
Flecainide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.00068	CcSEcCtD
Flecainide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.00068	CcSEcCtD
Flecainide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.00068	CcSEcCtD
Flecainide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000676	CcSEcCtD
Flecainide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000676	CcSEcCtD
Flecainide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000675	CcSEcCtD
Flecainide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000675	CcSEcCtD
Flecainide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000674	CcSEcCtD
Flecainide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000673	CcSEcCtD
Flecainide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000672	CcSEcCtD
Flecainide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.000669	CcSEcCtD
Flecainide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000177	0.000667	CcSEcCtD
Flecainide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000666	CcSEcCtD
Flecainide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000177	0.000666	CcSEcCtD
Flecainide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000177	0.000665	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000664	CcSEcCtD
Flecainide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000662	CcSEcCtD
Flecainide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000659	CcSEcCtD
Flecainide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000658	CcSEcCtD
Flecainide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000174	0.000655	CcSEcCtD
Flecainide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000654	CcSEcCtD
Flecainide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000653	CcSEcCtD
Flecainide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000653	CcSEcCtD
Flecainide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.00065	CcSEcCtD
Flecainide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000172	0.00065	CcSEcCtD
Flecainide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000649	CcSEcCtD
Flecainide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000649	CcSEcCtD
Flecainide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000648	CcSEcCtD
Flecainide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000647	CcSEcCtD
Flecainide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000647	CcSEcCtD
Flecainide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000647	CcSEcCtD
Flecainide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000647	CcSEcCtD
Flecainide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.000644	CcSEcCtD
Flecainide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000641	CcSEcCtD
Flecainide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00017	0.000641	CcSEcCtD
Flecainide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000633	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000633	CcSEcCtD
Flecainide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000629	CcSEcCtD
Flecainide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000629	CcSEcCtD
Flecainide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000628	CcSEcCtD
Flecainide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000624	CcSEcCtD
Flecainide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000624	CcSEcCtD
Flecainide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000623	CcSEcCtD
Flecainide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000623	CcSEcCtD
Flecainide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.00062	CcSEcCtD
Flecainide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000164	0.000619	CcSEcCtD
Flecainide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000164	0.000619	CcSEcCtD
Flecainide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000619	CcSEcCtD
Flecainide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000618	CcSEcCtD
Flecainide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.000614	CcSEcCtD
Flecainide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000614	CcSEcCtD
Flecainide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.000613	CcSEcCtD
Flecainide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000612	CcSEcCtD
Flecainide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000162	0.00061	CcSEcCtD
Flecainide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000605	CcSEcCtD
Flecainide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000604	CcSEcCtD
Flecainide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000601	CcSEcCtD
Flecainide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.0006	CcSEcCtD
Flecainide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.0006	CcSEcCtD
Flecainide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000599	CcSEcCtD
Flecainide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000599	CcSEcCtD
Flecainide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000598	CcSEcCtD
Flecainide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000598	CcSEcCtD
Flecainide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000596	CcSEcCtD
Flecainide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000594	CcSEcCtD
Flecainide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000594	CcSEcCtD
Flecainide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000587	CcSEcCtD
Flecainide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000155	0.000585	CcSEcCtD
Flecainide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000579	CcSEcCtD
Flecainide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000579	CcSEcCtD
Flecainide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.000578	CcSEcCtD
Flecainide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000576	CcSEcCtD
Flecainide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000576	CcSEcCtD
Flecainide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000576	CcSEcCtD
Flecainide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000573	CcSEcCtD
Flecainide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000571	CcSEcCtD
Flecainide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000151	0.00057	CcSEcCtD
Flecainide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000568	CcSEcCtD
Flecainide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000567	CcSEcCtD
Flecainide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000566	CcSEcCtD
Flecainide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.00056	CcSEcCtD
Flecainide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000552	CcSEcCtD
Flecainide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000549	CcSEcCtD
Flecainide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000549	CcSEcCtD
Flecainide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000544	CcSEcCtD
Flecainide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000543	CcSEcCtD
Flecainide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000541	CcSEcCtD
Flecainide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000539	CcSEcCtD
Flecainide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000539	CcSEcCtD
Flecainide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000538	CcSEcCtD
Flecainide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000536	CcSEcCtD
Flecainide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000535	CcSEcCtD
Flecainide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000523	CcSEcCtD
Flecainide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.00052	CcSEcCtD
Flecainide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000518	CcSEcCtD
Flecainide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000516	CcSEcCtD
Flecainide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000516	CcSEcCtD
Flecainide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000515	CcSEcCtD
Flecainide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000513	CcSEcCtD
Flecainide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000508	CcSEcCtD
Flecainide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000501	CcSEcCtD
Flecainide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000499	CcSEcCtD
Flecainide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000498	CcSEcCtD
Flecainide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000492	CcSEcCtD
Flecainide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000486	CcSEcCtD
Flecainide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000482	CcSEcCtD
Flecainide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000481	CcSEcCtD
Flecainide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000477	CcSEcCtD
Flecainide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000477	CcSEcCtD
Flecainide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000475	CcSEcCtD
Flecainide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000474	CcSEcCtD
Flecainide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000463	CcSEcCtD
Flecainide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.00046	CcSEcCtD
Flecainide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000459	CcSEcCtD
Flecainide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000459	CcSEcCtD
Flecainide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000456	CcSEcCtD
Flecainide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.00045	CcSEcCtD
Flecainide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000442	CcSEcCtD
Flecainide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000438	CcSEcCtD
Flecainide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000438	CcSEcCtD
Flecainide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000435	CcSEcCtD
Flecainide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000433	CcSEcCtD
Flecainide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000413	CcSEcCtD
Flecainide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	1.49e-05	0.104	CbGeAlD
Flecainide—SCN5A—digestive system—acquired immunodeficiency syndrome	1.14e-05	0.0804	CbGeAlD
Flecainide—SCN4A—nervous system—acquired immunodeficiency syndrome	1.14e-05	0.0802	CbGeAlD
Flecainide—CYP2D6—blood plasma—acquired immunodeficiency syndrome	1.12e-05	0.0784	CbGeAlD
Flecainide—SCN4A—central nervous system—acquired immunodeficiency syndrome	1.1e-05	0.0772	CbGeAlD
Flecainide—SCN5A—blood—acquired immunodeficiency syndrome	1.09e-05	0.0766	CbGeAlD
Flecainide—SCN5A—vagina—acquired immunodeficiency syndrome	1.01e-05	0.071	CbGeAlD
Flecainide—SCN5A—nervous system—acquired immunodeficiency syndrome	8.84e-06	0.0622	CbGeAlD
Flecainide—SCN4A—brain—acquired immunodeficiency syndrome	8.72e-06	0.0613	CbGeAlD
Flecainide—SCN5A—central nervous system—acquired immunodeficiency syndrome	8.51e-06	0.0599	CbGeAlD
Flecainide—SCN5A—brain—acquired immunodeficiency syndrome	6.76e-06	0.0475	CbGeAlD
Flecainide—CYP2C9—digestive system—acquired immunodeficiency syndrome	5.71e-06	0.0402	CbGeAlD
Flecainide—CYP2C9—blood—acquired immunodeficiency syndrome	5.44e-06	0.0383	CbGeAlD
Flecainide—CYP2D6—digestive system—acquired immunodeficiency syndrome	4.29e-06	0.0301	CbGeAlD
Flecainide—CYP2D6—blood—acquired immunodeficiency syndrome	4.09e-06	0.0287	CbGeAlD
Flecainide—CYP2D6—nervous system—acquired immunodeficiency syndrome	3.32e-06	0.0233	CbGeAlD
Flecainide—CYP2D6—central nervous system—acquired immunodeficiency syndrome	3.19e-06	0.0224	CbGeAlD
Flecainide—CYP2D6—brain—acquired immunodeficiency syndrome	2.53e-06	0.0178	CbGeAlD
